A 6-Month Extension Study of VMDN-003-2 to Assess Engensis in Participants With Painful Diabetic Peripheral Neuropathy

Completed · Phase 3 · Has a placebo group

Conditions studied: Diabetic Peripheral Neuropathy

In brief

To evaluate the durability of efficacy and long-term safety of intramuscular administration of Engensis or Placebo that was administered in the double-blind, randomized, VMDN-003-2 Placebo-controlled Phase 3 Study.

Key facts

Study ID
NCT04873232
Run by
Helixmith Co., Ltd.
People needed
106
Starts
2021-05-17
Expected to finish
2024-07-23
Last updated by the study team
2025-10-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.